Latest Content

The Invisibility of Blood Cancers to Others

June 6th 2025, 5:00pm

By Jane Biehl Ph.D.

Article

I describe what it is like to have an “invisible” cancer.

MVdeltaC Earns Orphan Drug Status for Pleural Mesothelioma

June 6th 2025, 3:00pm

By Spencer Feldman

Article

The FDA granted orphan drug designation to MVdeltaC, a measles virus-based immunotherapy, for pleural mesothelioma, supporting its future development.

Surgery Linked to Longer Survival in Oligometastatic Lung Cancer

June 6th 2025, 1:00pm

By Spencer Feldman

Article

Patients with oligometastatic lung cancer may live longer with surgery, but experts stress the need for multidisciplinary evaluation to guide treatment choices.

A Unicorn Among Us

June 5th 2025, 9:00pm

By Dr. Andrew Kuykendall

Article

Katherine has an exquisite instinct for understanding that there is a context to each patient’s diagnosis that is just as important to understand.

Understanding Supportive Care Needs in Younger Women With Cancer

June 5th 2025, 8:00pm

By Natalie Schnaitmann

Video

Natalie Schnaitmann discusses urgent supportive care gaps younger women with cancer encounter, and how they affect long-term quality of life.

Diving Into Every FDA Drug Approval for Cancer Care During May 2025

June 5th 2025, 7:00pm

By Ryan Scott

Article

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

Being in the Present Moment With Multiple Myeloma

June 5th 2025, 5:00pm

By Ronald Chin

Article

I reflect on finding peace, purpose and presence after my diagnosis through a creative writing exercise rooted in mindfulness and metaphor.

Columvi Combo Enhances Survival Outcomes in R/R Lymphoma Subgroup

June 5th 2025, 4:00pm

By Roman Fabbricatore

Article

Columvi plus chemo had enhanced survival outcomes vs Rituxan plus chemo in patients with relapsed/refractory diffuse large B-cell lymphoma.

Iopofosine-131 Earns FDA Breakthrough for Waldenstrom Macroglobulinemia

June 5th 2025, 3:07pm

By Spencer Feldman

Article

Iopofosine-131 received FDA breakthrough status for relapsed or refractory Waldenstrom macroglobulinemia, showing strong response rates in early trials.

High-Dose Radiation May Improve Survival in Lung Cancer Without Added Risk

June 5th 2025, 1:00pm

By Spencer Feldman

Article

Higher radiation doses in lung cancer treatment carry no added risk of inflammation and may improve survival.

Addressing Complications from ADT Therapy to Treat Prostate Cancer

June 4th 2025, 9:00pm

By Kristie L. Kahl

Article

Dr. Alicia Morgans discussed complications associated with ADT in prostate cancer, and how men can still maintain quality of life regardless.

New or Persistent Acid Reflux May Signal Esophageal Cancer Risk

June 4th 2025, 8:00pm

By Dr. Seper Dezfoli

Video

New or persistent acid reflux, especially after age 50, may mean higher risk for esophageal cancer, particularly in people with other known risk factors.